☆ 4.7 Article

Treatments, Trends, and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary Intervention

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 56, Issue 4, Pages 254-263

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2010.05.008

Keywords

acute myocardial infarction; percutaneous coronary intervention; NCDR

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Merck/Schering-Plough Corporation
  2. Bristol-Myers Squibb/Sanofi Pharmaceutical
  3. Eli Lilly
  4. Bristol-Myers Squibb
  5. Sanofi-Aventis
  6. Merck/Schering-Plough
  7. GlaxoSmithKline
  8. Novartis
  9. AstraZeneca
  10. Accumetrics
  11. Intekrin Therapeutics
  12. Merck
  13. Takeda
  14. ACCF
  15. Oklahoma Foundation for Medical Quality
  16. Lilly
  17. Johnson Johnson

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.